Literature DB >> 2619107

Marek's disease and major histocompatibility complex haplotypes in chickens selected for high or low antibody response.

A Martin1, E A Dunnington, W E Briles, R W Briles, P B Siegel.   

Abstract

Sublines of chickens differing in genotypes at the major histocompatibility complex (MHC) were developed from lines selected for high (HA) and low (LA) antibody response to sheep erythrocytes. To evaluate the influence of MHC genotypes in diverse background genomes on resistance to Marek's disease, chicks with MHC genotypes B13B13, B13B21 and B21B21 from both background genomes were exposed naturally commencing at 1 day of age. Individuals which died up to 120 days of age were autopsied to determine cause of death. Mortality due to Marek's disease was greater for HA than LA chickens and greater for males than females. Interactions of MHC genotypes with background genome and with sex suggest a complex picture of the influence of MHC genotypes. A heterozygous advantage for resistance to Marek's disease was noted, as would be predicted by genetic theory concerning maintenance of polymorphism at the MHC.

Entities:  

Mesh:

Year:  1989        PMID: 2619107     DOI: 10.1111/j.1365-2052.1989.tb00896.x

Source DB:  PubMed          Journal:  Anim Genet        ISSN: 0268-9146            Impact factor:   3.169


  3 in total

1.  Evolutionary analyses of non-genealogical bonds produced by introgressive descent.

Authors:  Eric Bapteste; Philippe Lopez; Frédéric Bouchard; Fernando Baquero; James O McInerney; Richard M Burian
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

2.  Association of LEI0258 Marker Alleles and Susceptibility to Virulent Newcastle Disease Virus Infection in Kuroiler, Sasso, and Local Tanzanian Chicken Embryos.

Authors:  Fulgence Ntangere Mpenda; Christian Keambou Tiambo; Martina Kyallo; John Juma; Roger Pelle; Sylvester Leonard Lyantagaye; Joram Buza
Journal:  J Pathog       Date:  2020-04-08

3.  Effect of human leukocyte antigen heterozygosity on infectious disease outcome: the need for allele-specific measures.

Authors:  Marc Lipsitch; Carl T Bergstrom; Rustom Antia
Journal:  BMC Med Genet       Date:  2003-01-24       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.